Trial Profile
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Roche
- 09 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2015 Planned End Date changed from 1 Nov 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 14 May 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.